Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 8656243

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
1996 Jun
First author
Tannock IF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 1996 Jun;14(6):1753-5. doi: 10.1200/JCO.1996.14.6.1753.
    note
    Source null
    related pmid
    8656242
    relationship
    Comment in
  2. citation
    J Clin Oncol. 1997 Jan;15(1):410-1. doi: 10.1200/JCO.1997.15.1.410.
    note
    Source null
    related pmid
    8996172
    relationship
    Comment in

Authors and identifiers

  1. name
    Tannock IF
    type
    Author
  2. name
    Osoba D
    type
    Author
  3. name
    Stockler MR
    type
    Author
  4. name
    Ernst DS
    type
    Author
  5. name
    Neville AJ
    type
    Author
  6. name
    Moore MJ
    type
    Author
  7. name
    Armitage GR
    type
    Author
  8. name
    Wilson JJ
    type
    Author
  9. name
    Venner PM
    type
    Author
  10. name
    Coppin CM
    type
    Author
  11. name
    Murphy KC
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Tannock IF
    type
    Author
  2. name
    Osoba D
    type
    Author
  3. name
    Stockler MR
    type
    Author
  4. name
    Ernst DS
    type
    Author
  5. name
    Neville AJ
    type
    Author
  6. name
    Moore MJ
    type
    Author
  7. name
    Armitage GR
    type
    Author
  8. name
    Wilson JJ
    type
    Author
  9. name
    Venner PM
    type
    Author
  10. name
    Coppin CM
    type
    Author
  11. name
    Murphy KC
    type
    Author
bibliography ids
  1. nci-bib-fb3ffab2a8b4ab4f127eae06
book metadata
content sha256
6da8140c6179767e1c87b379f8fa3a90bb4ffc5c2f26515c5185abcd9c8169cb
document type
citation
dois
  1. 10.1200/JCO.1996.14.6.1756
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:8656243
immutable id
pubmed:8656243@6da8140c6179767e1c87b379f8fa3a90bb4ffc5c2f26515c5185abcd9c8169cb
journal
abbreviation
J Clin Oncol
issn electronic
Source null
issn print
0732-183X
issue
6
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1756-64
volume
14
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 1996 Jun;14(6):1753-5. doi: 10.1200/JCO.1996.14.6.1753.
    note
    Source null
    related pmid
    8656242
    relationship
    Comment in
  2. citation
    J Clin Oncol. 1997 Jan;15(1):410-1. doi: 10.1200/JCO.1997.15.1.410.
    note
    Source null
    related pmid
    8996172
    relationship
    Comment in
outcomes validated
false
pmid
8656243
provenance
batch id
2752791f8cc3526b9192
provider
NCBI PubMed ESummary
record sha256
2f07d8e0d73c9e869d391defc25129bcdd33775dff34e2ab1efc7d186d215eb5
response sha256
8db42d042a938e99e944b9e6af6caf1dd877725c05485e70efac12add1ee08e9
retrieved at
2026-09-09T23:45:25.088603+00:00
publication date
display
1996 Jun
precision
month
year
1996
publication types
  1. Clinical Trial
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/8656243/
title
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

Preserved source evidence · Not medical advice